Skip to main content
. 2021 May 18;9(3):e00775. doi: 10.1002/prp2.775

TABLE 1.

Description of the five muscarinic receptor subtypes, their distribution throughout the body, and effect of agonism or antagonism at each muscarinic receptor subtype

Receptor Most common locations Functional response (agonism) Anticholinergic side effect (antagonism)
M1 Cerebral cortex, hippocampus and striatum, autonomic ganglia, gastric and salivary glands, enteric nerves

Increase cognitive function—learning and memory

Increase seizure activity

Delirium, sedation, confusion
M2 CNS, heart, smooth muscle, autonomic nerve terminals

Heart—SA node: slowed spontaneous depolarization, hyperpolarization, decrease HR

AV node: decrease conduction velocity

Atrium: decrease refractory period, decrease contraction

Ventricle: slight decrease in contraction

Increased heart rate, arrhythmia
M3 CNS, smooth muscle, and glands

Increase contraction (predominantly in bladder smooth muscle)

Increase secretion (predominant in salivary glands)

Increase tremor

Urinary retention, decreased salivation
M4 CNS forebrain Inhibition of neurotransmitter release Delirium, sedation, confusion
M5 Rare—CNS and periphery

Facilitates dopamine release

Involved with drug seeking behavior

Reduced drug seeking